InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Emergcy post# 32637

Wednesday, 01/02/2019 2:19:42 PM

Wednesday, January 02, 2019 2:19:42 PM

Post# of 232965
To be fair the problem right now with CYDY is money. It needs cash to finish filing the BLA in Q1 2019. AbbVie is loaded with cash and can get filings and products approved easily. Plus AbbVie has more experience with drug approvals since it has been doing it so long.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News